Liver Disease

March 03, 2022

The interplay between nonalcoholic fatty liver disease and diabetes can amplify both conditions, say two prominent researchers.

March 02, 2022

One of the priorities of the new institute at Virginia Commonwealth University’s medical school will be research into nonalcoholic steatohepatitis (NASH) as a key component in the emerging construct of metabolic health, says its leader, Arun J. Sanyal, M.D.

March 01, 2022

Researchers say their results suggest that clinicians should consider nonalcoholic fatty liver disease a risk factor for hypoglycemia among their patients with type 2 diabetes.

February 02, 2022

Results of an AstraZeneca trial presented at a recent ASCO meeting sow hopes for a new treatment for patients diagnosed with unresectable hepatocellular carcinoma, the most common type of liver cancer.

February 01, 2022

Findings reported in JAMA Network Open show that patients with chronic hepatitis B didn’t reap the benefits of price competition as the number of generic suppliers of the antiviral increased from one to 11.

January 28, 2022

Although systemic therapy improves survival for patients with advanced unresectable hepatocellular carcinoma (HCC), uptake was low and dose reductions were common, according to a real-world Canadian study.

January 25, 2022

The introduction of an electronic tracking system decreased the time from hepatocellular carcinoma (HCC) diagnosis to treatment by more than a month.

January 03, 2022

'Just do it' is the takeaway from a review of 19 studies that found no difference between bouts of high-intensity physical activity and more moderate forms of aerobic exercise when it comes reducing liver fat.

January 02, 2022

Excessive drinking has increased 21% during the pandemic.

January 01, 2022

A study conducted in China shows an association between metabolic-associated fatty liver disease and air pollution.